Handling Uncertainty in Cost-Effectiveness Models
Top Cited Papers
- 1 May 2000
- journal article
- review article
- Published by Springer Nature in PharmacoEconomics
- Vol. 17 (5) , 479-500
- https://doi.org/10.2165/00019053-200017050-00006
Abstract
The use of modelling in economic evaluation is widespread, and it most often involves synthesising data from a number of sources. However, even when economic evaluations are conducted alongside...Keywords
This publication has 60 references indexed in Scilit:
- An Introduction to Markov Modelling for Economic EvaluationPharmacoEconomics, 1998
- Accounting for future costs in medical cost-effectiveness analysisJournal of Health Economics, 1997
- The friction cost method for measuring indirect costs of diseaseJournal of Health Economics, 1995
- Costs, effects and C/E‐ratios alongside a clinical trialHealth Economics, 1994
- A Cost‐Utility Analysis of Misoprostol Prophylaxis for Rheumatoid Arthritis Patients Receiving Nonsteroidal Antiinflammatory DrugsArthritis & Rheumatism, 1994
- Discounting in Cost-Effectiveness Analysis of Healthcare ProgrammesPharmacoEconomics, 1993
- Discounting of Health Benefits in the Pharmacoeconomic Analysis of Drug TherapiesPharmacoEconomics, 1992
- A Bayesian Method for Synthesizing Evidence: The Confidence Profile MethodInternational Journal of Technology Assessment in Health Care, 1990
- Decision AnalysisNew England Journal of Medicine, 1987
- Probabilistic sensitivity analysis methods for general decision modelsComputers and Biomedical Research, 1986